AS-IV [43] inhibits the expression of p-PI3K, p-Akt, and p-mTOR, thereby inhibiting the proliferation of lung and liver cancer cells through the PI3K/Akt/mTOR signaling pathway. The gene discussed is AKT1; the disease is liver cancer.